IRF5 and cancer: Additionally, PHY906 enhanced the expression of IRF-5, another potent pro-inflammatory transcription factor associated with immune-mediated, tissue-specific rejection [33-36] as well as induction of apoptosis of CPT-11 treated cancers [30].